NCT01069783View on ClinicalTrials.gov

Study of A3309 in Patients With Dyslipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Dyslipidemia
Interventions
DRUG

A3309

A3309 in two different dosage levels

DRUG

A3309

A3309 in two different dosage levels for the duration of the study

DRUG

Placebo

Placebo comparator once daily for the duration of the trial

Trial Locations (1)

Unknown

BCRC, Linköping

Sponsors

Lead Sponsor

Albireo
All Listed Sponsors
lead

Albireo

INDUSTRY